Stockreport

ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update [TheStreet.com]

ZyVersa Therapeutics, Inc.  (ZVSA) 
PDF LIGHTHOUSE POINT, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (OTCQB: ZVSA), a clinical-stage specialty biopharmaceutical company developing fir [Read more]